Histone Demethylase Inhibitors
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 62/051,691, filed Sep 17, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,643,965 | Histone Demethylase Inhibitors In force · High confidence | Celgene Quanticel Research, Inc. | In force | High confidence | ||
| US 10,112,940 | Histone Demethylase Inhibitors Grace period ended Oct 30, 2026 · lapse expected · Low confidence | Celgene Quanticel Research, Inc. | Grace period ended Oct 30, 2026 lapse expected | Low confidence | ||
| US 10,202,381 | Histone Demethylase Inhibitors In force · Medium confidence | Celgene Quanticel Research, Inc. | In force | Medium confidence | ||
| US 10,208,039 | Histone Demethylase Inhibitors In force · Medium confidence | Celgene Quanticel Research, Inc. | In force | Medium confidence | ||
| US 10,611,763 | Histone Demethylase Inhibitors In force · High confidence | Celgene Quanticel Research, Inc. | In force | High confidence | ||
| US 10,815,234 | Histone Demethylase Inhibitors In force · High confidence | Celgene Quanticel Research, Inc. | In force | High confidence | ||
| US 12,172,998 | Histone Demethylase Inhibitors In force · High confidence | Celgene Quanticel Research, Inc. | In force | High confidence | ||
| US 11,535,616 | Histone Demethylase Inhibitors In force · High confidence | Celgene Quanticel Research, Inc. | In force | High confidence | ||
| Application 18/935,237 | Histone Demethylase Inhibitors Pending Not granted | Celgene Quanticel Research, Inc. | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
8 of these are in force and held by Celgene Corporation.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.